UTILITY OF GENETIC SCREENING FOR COLORECTAL CANCER RISK ASSESSMENT
Grant number: 1117611 | Funding period: 2017 - 2021
Bowel cancer can be prevented by regular screening, however screening is not targeted to those most at risk and only 30% take up the offer. My research will determine how effective genetic testing of the general population might be as an innovative approach to target screening to those most at risk. I will use data from existing and funded studies that I lead, and will collaborate with colleagues in my research team that have the necessary expertise in this area, to address this question issue.
Related publications (3)
An integrated mass spectrometry imaging and digital pathology workflow for objective detection of colorectal tumours by unique atomic signatures
Bence Paul, Kai Kysenius, James B Hilton, Michael WM Jones, Robert W Hutchinson, Daniel D Buchanan, Christophe Rosty, Fred Fryer, Ashley Bush, Janet M Hergt, Jon D Woodhead, David P Bishop, Philip A Doble, Michelle M Hill, Peter J Crouch, Dominic J Hare
Tumours are abnormal growths of cells that reproduce by redirecting essential nutrients and resources from surrounding tissue. Cha..
Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
Rohit Hariharan, Mark Jenkins
Background: Circulating tumour DNA from colorectal cancer (CRC) is a biomarker for early detection of the disease and therefore po..